PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsrEVO Biologics
rEVO Biologics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AtrynAntithrombin alfa2009-02-06
Antithrombin iii deficiency
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Antithrombin alfa
congenital heart defects
,
postoperative hemorrhage
,
healthy volunteers/patients
,
renal dialysis
,
covid-19
,
sepsis
,
liver cirrhosis
,
syndrome
,
liver failure
,
hepatic insufficiency
,
venous thromboembolism
,
thromboembolism
,
reperfusion injury
,
coronary artery bypass
,
respiratory distress syndrome
,
severe acute respiratory syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
hepatic veno-occlusive disease
,
end stage liver disease
,
fibrosis
,
acute-on-chronic liver failure
,
wounds and injuries
,
blood coagulation disorders
,
hemostatic disorders
,
venous thrombosis
,
cardiopulmonary bypass
,
disseminated intravascular coagulation
,
extracorporeal membrane oxygenation
,
menopause
,
antithrombin iii deficiency
,
thrombosis
,
hemorrhage
,
hemophilia a
,
thrombophilia
,
pre-eclampsia
,
myocardial infarction
,
infarction
,
cardiac surgical procedures
,
acute coronary syndrome
,
aortic valve stenosis
,
aortic valve insufficiency
,
mitral valve insufficiency
,
mitral valve stenosis
,
toxemia
,
coagulation protein disorders
,
congenital disorders of glycosylation
,
atrial fibrillation
,
embolic stroke
,
recurrence
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
sickle cell anemia
,
hemolysis
,
hemolytic anemia
,
heart failure
,
thrombocytopenia
,
environmental biomarkers
,
postmenopause
,
cicatrix
,
burns
,
factor xiii deficiency
,
migraine disorders
,
acute-phase reaction
,
antiphospholipid syndrome
,
malnutrition
,
fatal outcome
,
cytokine release syndrome
,
septic shock
,
upper extremity deep vein thrombosis
,
nephritis
,
transfusion reaction
,
liver transplantation
,
heart diseases
,
heart septal defects
,
pancreatitis
,
acute kidney injury
,
portal hypertension
,
embolism
,
budd-chiari syndrome
,
chronic renal insufficiency
,
post-acute covid-19 syndrome
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
Benzocaine
antithrombin iii deficiency
,
thrombosis
,
venous thrombosis
Serine
neoplasms
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
neoplasm metastasis
,
hematologic neoplasms
,
neurofibromatosis 1
,
neurofibrosarcoma
,
neurofibromatoses
,
nerve sheath neoplasms
,
breast neoplasms
,
non-small-cell lung carcinoma
Bevifimod
neoplasms
Nadide
endocrine system diseases
,
laron syndrome
,
pituitary dwarfism
,
pituitary diseases
Crystalloid
chronic kidney failure
,
bullous pemphigoid
,
hemolytic anemia autoimmune
,
parkinson disease
,
covid-19
,
diarrhea
,
human influenza
,
h1n1 subtype influenza a virus
,
healthy volunteers/patients
,
tuberculosis
,
pseudomembranous enterocolitis
,
viremia
,
west nile fever
,
clostridium infections
,
encephalitis
,
japanese encephalitis
,
sepsis
,
septic shock
,
heart transplantation
,
reperfusion injury
Rfviia
hemophilia a
,
type 3 von willebrand disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use